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Abstract
Background: to recognize ocular presentations in cra-
nial venous sinus thrombosis (CVst) which were easy
to be misdiagnosis.
Design: Retrospective study. 
Methods: Review clinical informations including gener-
al informations, general performances, and ocular pre-
sentations of 118 inpatients with CVst in the general
hospital  of  chinese  people’s  liberation  army  during
2005-2009. 
Main Outcome Measures: the ocular symptoms as the
initial onset presentations or simultaneous phenome-
non  among  different  onset  type  patients  were  ana-
lyzed.
Results: of  all  the  CVst  patients,  21.2%  (25/118)
presented with ocular symptom as the initial presenta-
tion, 30.5% (36/118) presented with ocular symptom
as well as the other symptoms, and 48.3% (57/118)
presented with non-ocular symptoms as the initial on-
set. the CVst patients were divided into 3 groups ac-
cording to the onset type. there was no marked statis-
tical  significance  among  groups.  the  most  common
major complaints were blurring and degeneration of
acute vision, accounting for 85.9% (61/71) of all ab-
normal ocular chief complaints. the most common
objective  sign  in  eyes  was  papilloedema,  accounting
for 48.3% (57/118) in this group of CVst patients.
About 22.4% (13/58) showed acute vision deteriora-
tion at 1-year follow-up, due to optic atrophy. 
Conclusions: As  ophthalmologists,  we  should  master
the onset characteristics and clinical manifestations of
CVst. Early diagnosis and treatment is very important
for the prevention of vision deterioration, especially
for patients with ocular syndrome as the initial onset
syndrome. for isolated agnogenic intracranial hyper-
tension, we should consider the possibility of CVst. 
Keywords:  Cranial  venous  sinus  thrombosis;  ocular
presentations; Papilloedema 
IntRoDuCtIon
Cranial venous sinus thrombosis (CVst) is a specific
type of cerebrovascular disease. Patients present signs
of intracranial hypertension, such as headache, vomit-
ing,  and  papilloedema,  which  are  common  clinical
manifestations.  because  ocular  onset  presentation  is
the  most  common  symptom,  some  patients  may  be
misdiagnosed or a missed diagnosis may occur if only
ocular  onset  presentation  occurs  as  the  initial  onset
symptom. In recent years, the popularity of some tech-
nical applications, including magnetic resonance imag-
ing  (MRI),  magnetic  resonance  venography  (MRV),
and digital subtraction angiography (DsA) has resulted
in ongoing improvements in diagnosis and increased
levels of awareness of this disease. Although there are
many  reported  clinical  observations  of  CVst  [1-4],
there are few reports on the study of the interrelation-
ship between the clinical manifestations and ocular on-
set presentation. to this end, we collected the informa-
tion of 118 inpatients with CVst and treated the data
with a retrospective analysis for the period 2005-2009.
We expected that it would provide more clinically sig-
nificant data for the early diagnosis and treatment of
CVst.
MEtHoDs
the aim was to study 118 inpatients with a retrospec-
tive analysis, in the Department of neurology and In-
terventional section, the General Hospital of Chinese
People’s liberation Army, during 2005-2009. of 118
CVst patients, the numbers of men and women are
53 and 65, respectively; the gender constituent ratio is
1:1.2 (men: women). the onset age ranged from 15 to
67 years: average age was 34.9 ﾱ 10.6(mean ﾱ sD) and
between 20 and 45 was most common; the initial onset
ages  were  concentrated  between  30  and  40  years.
Causes of CVst included infectious (the number of
cases of upper respiratory tract infection and diarrhea
was 12 and the number of cases of otitis media and
mastoiditis were 7 and 3, respectively) and non-infec-
tious origins (the number of cases of puerperium, hy-
perlipidemia, oral contraceptive use, trauma, postoper-
ative or agnogenic were 9, 3, 8, 10, and 66, respective-
ly). not only the clinical symptoms and systemic ex-
amination,  but  also  definitive  diagnosis  of  CVst  is
mainly identified by DsA (fig.1). Most of the sites of
thrombosis are multiple: 23.7% (28/118) of the CVst
patients presented with simple superior sagittal sinus
thrombosis; 24.6% (29/118) presented with simple lat-
eral  sinus  thrombosis;  3.4%  (4/118)  presented  with
purely straight sinus thrombosis; 26.3% (31/118) pre-
sented with superior sagittal sinus thrombosis in com-
bination with lateral sinus thrombosis; 2.5% (3/118)
presented  with  cavernous  sinus  thrombosis;  3.4%
(4/118) presented with intracranial large in combina-
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5. Wang_Umbruchvorlage  12.07.11  11:33  Seite 324tion with small vein thrombosis; 8.5% (10/118) pre-
sented with thrombosis in more than 3 sites; and 4.2%
(5/118) of the CVst patients presented not only with
thrombosis, but also dural arteriovenous fistula forma-
tion. All patients were given a cerebrospinal fluid ex-
amination.  In  these  results,  the  cerebrospinal  fluid
pressure  was  measured  at  up  to  700  mmH2o  (1
mmH2o = 0.133 kPa). the results ranged mostly be-
tween 300 and 400 mmH2o. of the 95 patients who
received an MRI examination, 42.3% (41/95) present-
ed abnormal changes, including 10 patients with emp-
ty sella (fig. 2). the eye is mainly given an external oc-
ular examination and fundus examination with a direct
ophthalmoscope  (fig.  3).  All  patients  received  treat-
ments  during  hospitalization,  such  as  thrombolytic
therapy intervention with transcranial venous sinus in-
tubation,  carotid  arteriopuncture  and  anticoagulant
therapy with oral anticoagulant. Patients had follow-up
inspections for about 1 year. the CVst patients were
divided into 3 groups according to the onset style [1,
4]. these were acute onset (less than 2 days), subacute
onset (between 2 days and 1 month), and chronic on-
set (more than 1 month). the main components of
retrospective analysis were correlation analysis of gen-
eral information, general performance, and ocular on-
set presentation of this group of patients, and deter-
mining whether there were differences of the ocular
symptoms as the initial onset among different onset
patients. statistical analysis was determined using re-
sults from sPss 10.0, using a ˇ2 test, at a P < 0.05 lev-
el of significance. this study was approved by the in-
stitutional review board of the Department of oph-
thalmology, General Hospital of Chinese People’s lib-
eration  Army  (beijing,  China)  and  written  informed
consent was obtained from every participant.
REsults
of the CVst patients, 21.2% (25/118) presented with
ocular symptoms as the initial onset. All of these pa-
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Fig. 1. Photochrome of binoculus with CVst. papilloedema, and varicosity of both eyes. Retinal hemorrhage of the left eye. 
Fig. 2. MRI showing high signals involving the superior sagit-
tal sinus thrombosis on tW1.
Fig. 3. DsA interal carotid arteriography lateral view did not dis  -
play the superior sagittal sinus in venous phase (black arrow).
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Ct or MRI as screening tools in order to exclude ocu-
lar  disease  and  other  intracranial  lesions;  30.5%
(36/118) of the CVst patients presented with ocular
syndrome  in  conjunction  with  other  syndromes  (in-
cluding headache, dizziness, nausea, vomiting, convul-
sions, disturbance of consciousness, tinnitus, hearing
loss, and limb movement disorder); 48.3% (57/118) of
the CVst patients presented with non-ocular symp-
toms as the initial onset (mainly headache, nausea, and
vomiting). there was no significant difference of ocu-
lar  presentation  incidence  as  the  initial  symptom
among the 3 groups (table 1). of the CVst patients,
60.2% (71/118) presented with ocular onset presenta-
tion  as  the  chief  complaint.  symptoms  included
blurred vision, vision loss, transient amaurosis, diplop-
ia, ophthalmalgia, metamorphopsia, and abnormal vi-
sion. of these patients, 85.9% (61/71) presented with
blurred vision and vision loss; 30.9% (22/71) present-
ed with diplopia; 19.7% (14/71) presented with oph-
thalmalgia (mainly gas pains). of the CVst patients,
70.3%  (80/118)  presented  with  an  abnormal  ocular
examination. the CVst patients exhibit not only vi-
sion loss, metamorphopsia, and diplopia, but also the
symptoms of eyeball movement restriction, conjuncti-
val hyperemia, exophthalmos, nystagmus, and fundus
changes.  the  symptoms  of  fundus  changes  include
papilloedema,  optica  trophy,  optic  disc  hemorrhage,
retinal hemorrhage, retinal varices, and macular ede-
ma. Papilloedema is the most common symptom, ac-
count for 68.7% (57/83) of this group of patients. A
year later, after the follow-up inspection, there were 58
patients  with  complete  information:  51.7%  (30/58)
presented  a  reduction  in  ocular  onset  presentation,
and 22.4% (13/58) of these patients presented serious
vision loss because of optic atrophy.
DIsCussIon
DsA with high sensitivity is the key standard of diag-
nosis of CVst: Accuracy ranges from 75% to 100%
[5]. Although MRI and MRV have some advantages
for checking venous sinus thrombosis, such as being
non-invasive, having repeatability and high-resolution,
they  are  not  effective  with  smaller  vascular  throm-
boses. Diagnosis using MRI and MRV is difficult also
because  of  the  anatomical  variants  of  venous  sinus
[6]. DsA not only displays the filling state of venous
sinus (including symptoms of venous sinus filling de-
fect,  underdevelopment,  backflow,  and  anastomosed
varicose vein), but also can analyze the cycle time of
cerebral arteriovenous cycles in the arterial phase, cap-
illary phase, venous phase, and sinus period to con-
firm which period is delayed when there is an exten-
sion of the total cycle time. because all the patients re-
ceived the DsA examination to make a definite diag-
nosis, so the patients we enrolled were accurate and
credible. the average age of onset for these patients is
34.9 ﾱ 10.6 years, and it affects slightly more females
than males-match with the reported literatures [7, 8].
females aged from 20 to 35 are most commonly af-
fected which may relate to pregnancy, childbirth, and
use of oral contraceptive according to other reports
[4]. In this study, we do not make any further analysis
of the relevant factors of this phenomenon, but there
was a study showed that CVst was related to anti-
phospholipid antibody syndrome [9]. 
the clinical manifestation of CVst is complex and
non-specific. Its main symptoms are intracranial hy-
pertension and cortical damage. Headache is the most
common symptom, accounting for 74-90% of CVst
patients;  70-75%  of  this  group  presented  with
headache as the initial onset symptom [3, 10]. Howev-
er,  20%-40%  of  the  CVst  patients  only  presented
with benign intracranial hypertension [11]. over 75%
of patients in this group mainly complained of serious
headache,  and  this  corresponds  to  the  reports.  It
should be noted that 21.2% of CVst patients present-
ed with ocular syndrome as the initial onset and 30.5%
of the CVst patients presented with ocular syndrome
simultaneously  with  other  syndromes  in  this  group.
the ocular onset presentation has no relationship to
the onset symptoms. so the ophthalmologist must pay
attention to, and be familiar with CVst to avoid mis-
diagnosis and a missed diagnosis when patients pre-
sent with ocular symptom as the initial onset symp-
tom. 
At  present,  it  is  believed  that  underlying  ocular
symptom  of  CVst  are  venous  obstruction  and  in-
tracranial  hypertension.  the  most  common  ocular
symptom is papilloedema. In this group of patients,
48.3% had papilloedema; this corresponds to the re-
ported  41%  [12].  unless  the  macular  is  affected  by
retinal hemorrhage, retinal edema, or exudation, there
are no identifiable symptoms of early papilloedema,
not even vision changes or impaired vision. If the pa-
pilloedema caused by intracranial hypertension lasted
too long, it would cause progressively deteriorating vi-
sion in narrow irregular concentric circles – a result of
optic nerve fiber damage. this would eventually result
in seriously impaired vision or blindness caused by op-
tic atrophy [13].
the  pathogenesis  of  papilloedema  by  intracranial
hypertension is unclear and controversial. the general-
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Table 1. Initial presentation with different onset style of 118 patients.
onset style ocular ocular with other other total
number number number
Acute onset 57 11 23
subacute onset 8 11 19 37
Chronic onset 12 18 27 58
total 25 36 57 118
ˇ 2 = 0.0900 ʳ = 4 P = 0.9990
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ly accepted mechanism is that blockage in axoplasmic
flow of the optic nerve causes papilloedema [14]. the
prognosis for long-term and serious papilloedema is
very poor, so we must actively treat the patient before
the papilloedema develops and optica trophy occurs.
once the opportunity for treatment is missed, it would
be difficult to retrieve lost vision.
In addition, the intracranial hypertension leads to
eighth cranial nerve paralysis and mild cognitive im-
paired.  some  patients  presented  with  diplopia  and
strabismus because of intracranial hypertension. the
cause  may  due  to  the  eighth  cranial  nerve  having  a
long itinerary in the cranial cavity, it is easily damaged.
this group had 6 patients with diplopia and strabis-
mus. there is a complex relationship between CVst
and dural arteriovenous fistula. According to some re-
ports, there may be a dural arteriovenous fistula in the
terminal stage of CVst [15, 16]. In this group, there
are 5 patients with dural arteriovenous fistula. these
patients  were  diagnosed  with  CVst  via  DsA  6
months to 3 years ago. Each patient presented with
the related symptoms of arteriovenous fistula. In addi-
tion, the dural arteriovenous fistula may have already
existed  before  thrombosis,  so  it  might  be  the  basic
cause of CVst [17].
We have analyzed and summarized the data of 118
patients with CVst over 5 years. this has allowed a
deepened recognition of ocular onset presentation of
CVst but, in this study, we have not analyzed the rela-
tionship  between  the  severity  level  of  ocular  onset
presentation and the site of thrombosis which need
further study. 
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